Stephen Lermer joined as the Company’s Chief Operating Officer in January 2019. Mr. Lermer oversees all aspects of the Company’s manufacturing, supply chain, research & development, legal and regulatory affairs, quality assurance and control, engineering, cultivation and operations management functions. Mr. Lermer has over 38 years of experience overseeing start-up, mid and large-scale global pharmaceutical, cosmetic and consumer-packaged goods (“CPG”) operations, product development and commercialization, and manufacturing and distribution. He comes to Charlotte’s Web from the pharmaceutical industry, where he held senior leadership and executive positions at DuPont, Johnson & Johnson, Burroughs Wellcome (now GlaxoSmithKline), Rhone Poulenc (now Sanofi), Orion Oyj and Akela Pharma.
He also brings a seasoned global business perspective to operational decision making having lived and worked in Europe, the Caribbean, Central America, South America and North America. Mr. Lermer’s deep international business experience includes cross border mergers & acquisitions, international drug development and new market entry experience.